Profusa Stock
PROFUSA is a medical devices company creating tissue-integrated sensors for chronic disease management and healthy living.
Sign up today and learn more about Profusa Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Profusa Stock
Profusa, Inc. operates in the health care sector. The company was incorporated in 2009 and is based in Cupertino, California.
Funding History
| August 2012 | $1.2M |
|---|---|
| September 2013 | $2.8M |
| July 2015 | $11.3M |
| December 2015 | $13.2M |
| July 2016 | $7.5M |
| August 2018 | $45.0M |
Management
Chairman and CEO
Ben Hwang
Founder, Chief Executive Officer
William McMillan
Co-founder, President and Chief Scientific Officer
William McMillan
Co-Founder and CTO
Natalie Wisniewski
Press
prnewswire - Mar, 4 2020
Profusa and Partners Announce Initiation of Study to Measure Early Signs of Influenza Through Biosensor Technologyprnewswire - Jan, 28 2020
Profusa Receives CE Mark Approval to Market the Wireless Lumee® Oxygen Platform for Continuous, Real-Time Monitoring of Tissue Oxygenfiercebiotech - Feb, 12 2019
Profusapehub - Aug, 15 2018
Profusa garners over $45 mln Series CEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
